DataMeds AI, Inc. (MEDS)
4.19
+0.43
(+11.44%)
USD |
NASDAQ |
Sep 21, 16:00
4.17
-0.02
(-0.48%)
After-Hours: 20:00
DataMeds AI Enterprise Value : 41.00M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 41.00M |
| September 17, 2026 | 43.49M |
| September 16, 2026 | 47.55M |
| September 15, 2026 | 34.93M |
| September 14, 2026 | 32.79M |
| September 11, 2026 | 32.89M |
| September 10, 2026 | 32.86M |
| September 09, 2026 | 32.75M |
| September 08, 2026 | 32.80M |
| September 04, 2026 | 32.93M |
| September 03, 2026 | 33.06M |
| September 02, 2026 | 33.25M |
| September 01, 2026 | 33.14M |
| August 31, 2026 | 33.06M |
| August 28, 2026 | 33.06M |
| August 27, 2026 | 33.65M |
| August 26, 2026 | 34.12M |
| August 25, 2026 | 34.19M |
| August 24, 2026 | 34.02M |
| August 21, 2026 | 34.22M |
| August 20, 2026 | 34.44M |
| August 19, 2026 | 34.39M |
| August 18, 2026 | 34.25M |
| August 17, 2026 | 34.56M |
| August 14, 2026 | 34.53M |
| Date | Value |
|---|---|
| August 13, 2026 | 34.56M |
| August 12, 2026 | 34.10M |
| August 11, 2026 | 34.27M |
| August 10, 2026 | 34.87M |
| August 07, 2026 | 35.98M |
| August 06, 2026 | 37.82M |
| August 05, 2026 | 38.27M |
| August 04, 2026 | 39.32M |
| August 03, 2026 | 39.52M |
| July 31, 2026 | 38.90M |
| July 30, 2026 | 39.30M |
| July 29, 2026 | 38.84M |
| July 28, 2026 | 40.40M |
| July 27, 2026 | 39.18M |
| July 24, 2026 | 39.32M |
| July 23, 2026 | 39.64M |
| July 22, 2026 | 40.49M |
| July 21, 2026 | 40.32M |
| July 20, 2026 | 38.02M |
| July 17, 2026 | 37.85M |
| July 16, 2026 | 37.88M |
| July 15, 2026 | 38.39M |
| July 14, 2026 | 38.64M |
| July 13, 2026 | 38.59M |
| July 10, 2026 | 39.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Exlites Holdings International, Inc. | 21.57M |
| Xcelerate, Inc. | 10.26M |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | 1.943M |
| Vivos Therapeutics, Inc. | 14.04M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.36M |
| Revenue (Quarterly) | 1.780M |
| Total Expenses (Quarterly) | 20.14M |
| EPS Diluted (Quarterly) | -7.132 |
| Gross Profit Margin (Quarterly) | -9.80% |
| Profit Margin (Quarterly) | -1.03K% |
| Earnings Yield | -1.03K% |
| Normalized Earnings Yield | -840.91 |